SpringWorks Therapeutics ...

47.41
-0.08 (-0.17%)
At close: Mar 28, 2025, 3:59 PM
47.48
0.15%
After-hours: Mar 28, 2025, 07:18 PM EDT

SpringWorks Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 191.59M 5.45M 6.15M n/a 35M n/a n/a n/a
Cost of Revenue 12.55M 422K 1.9M 490K 349K 192K 17.33K 3.18K
Gross Profit 179.04M 5.03M 4.25M -490K 34.65M -192K -17.33K -3.18K
Operating Income -278.13M -343.01M -280.67M -173.47M -46.32M -59.24M -18.49M -4.66M
Interest Income 26M 22.95M 6.15M 698K 1.33M 3.55M 678K 63K
Pretax Income -258.13M -325.1M -277.42M -173.91M -45.57M -58.31M -17.81M -4.64M
Net Income -258.13M -325.1M -274.16M -173.21M -44.24M -54.76M -17.81M -4.64M
Selling & General & Admin 256.65M 197.55M 134.55M 71.79M 29.46M 16.69M 8.59M 1.86M
Research & Development 200.52M 150.49M 146.12M 101.68M 51.86M 42.55M 9.9M 2.8M
Other Expenses n/a n/a -138K -152K 25K n/a n/a n/a
Operating Expenses 457.17M 348.04M 280.67M 173.47M 81.32M 59.24M 18.49M 4.66M
Interest Expense n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a -3.73M
Cost & Expenses 469.72M 348.46M 280.67M 173.47M 81.32M 59.24M 18.49M 4.66M
Income Tax n/a n/a -3.26M -698K -1.33M -3.55M 678K -2
Shares Outstanding (Basic) 74.13M 63.12M 53.29M 48.5M 43.3M 43.01M 22.2M 43.23M
Shares Outstanding (Diluted) 74.13M 63.12M 53.29M 48.5M 43.3M 43.01M 22.2M 43.23M
EPS (Basic) -3.48 -5.15 -5.14 -3.57 -1.02 -1.27 -0.8 -0.11
EPS (Diluted) -3.48 -5.15 -5.14 -3.57 -1.02 -1.27 -0.8 -0.11
EBITDA -278.13M -341.35M -280.67M -172.98M -45.98M -59.05M -18.47M -4.64M
Depreciation & Amortization n/a 1.67M 1.9M 490K 349K 192K 17.33K 3.18K